ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: FR-PO1059

RNF213 p.Arg4810Lys Variant Screening in Renovascular Hypertension in Korean Children

Session Information

Category: Hypertension and CVD

  • 1402 Hypertension and CVD: Clinical, Outcomes, and Trials

Authors

  • Cho, Heeyeon, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea (the Republic of)
  • Kim, Jeong yeon, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea (the Republic of)
Background

Moyamoya disease (MMD) -a steno-occlussive disease of the distal cerebral arteries- is often accompanied by renovascular hypertension (RVH), and a variant of RNF213 p.Arg4810Lys is known as a susceptibility gene of MMD. There is a report for a RNF213 variant-associated vasculopathy with peripheral pulmonary arterial stenosis and homozygous variant for RNF213 p.Arg4810Lys without the presence of MMD. The purpose of this study was to evaluate clinical manifestations and gene test for the RNF213 variant in Korean pediatric patients with initially presenting with isolated RVH.

Methods

A retrospective analysis of medical records in pediatric patients with isolated RVH from January 2001 to October 2017 were performed. The presence of renovascular hypertension was confirmed by computer tomography (CT) angiography or renal doppler ultrasonography. The genetic test for RNF213 variant was performed in the pediatric patients with RVH.

Results

The gene test for RNF213 was performed in 11 patients with isolated RVH. The molecular testing revealed homozygosity of RNF213 p.Arg4810Lys in 5 patients, and heterozygosity in 2 patients. Among 7 patients with RNF213 variant, on CT angiography, it revealed bilateral renal artery stenosis of ostial lesions in 3 of the patients and unilateral stenosis of ostial to proximal lesions in 4 of the patients. Among 7 patients with RNF213 variant, MMD developed in 4 patients during follow-up. In one patient with homozygosity of RNF213 p.Arg4810Lys, he showed the isolated RVH, and his mother with heterozygosity of RNF213 p.Arg4810Lys presented with MMD and no evidence of RVH.

Conclusion

Our study suggests that RNF213 may be the causative gene in RVH in Korean children. The screening for MMD and other organ involvement might be helpful in children and family members with RVH and RNF213 variant.

CasesexRNF213Brain imageTime interval
RVHT →MMD
Family History
1FHomoMMD2 monthsSibling: case 2, MMD (+), RVHT (+)
2FHomoMMD1 weekSibling: case 1, MMD (+), RVHT (+)
3MHomonormal-NA
4MHeteronormal-Twin Brother (hetero) , MMD (-), RVHT (-)
5FHeteroMMD6 yearsMother(hetero), MMD (+), RVHT (-)
6MHomonormal-Father (hetero), MMD (-), RVHT (-)
Mother (hetero), MMD (+), RVHT (-)
Elder brother (Hetero), MMD (-), RVHT (-)
Elder sister (Homo), MMD (-), RVHT (+)
7MHomoMMD10 yearsFather (hetero), MMD (+), RVHT (-)
Mother (hetero), MMD (-), RVHT (-)
Younger sister (Hetero), MMD (-), RVHT (-)